SciDev.Net

At its global summit next week the G8 needs to build on the work of its predecessors, putting science and technology back at the heart of the international aid agenda.

Pressure is growing for a major shift in international intellectual property rules that addresses the interests of the poor.

Increasing access to affordable drugs in developing countries requires better government intervention, not less of it.

Proposals for a global treaty to boost research and development for neglected diseases by sidelining large pharmaceutical companies may appear utopian. But they highlight the urgent need for new ways of producing the medicines needed by the poor.